(Q40681909)

22 September 2017

title

Modulation of estrogen receptor alpha function and stability by tamoxifen and a critical amino acid (Asp-538) in helix 12. (English)

1 reference

22 September 2017

1 reference

3

V Craig Jordan

1 reference

22 September 2017

Sandra Timm Pearce

1

1 reference

22 September 2017

Hong Liu

series ordinal

2

1 reference

22 September 2017

language of work or name

English

0 references

publication date

20 December 2002

1 reference

Journal of Biological Chemistry

22 September 2017

published in

1 reference

22 September 2017

volume

278

1 reference

22 September 2017

issue

9

1 reference

22 September 2017

page(s)

7630-7638

1 reference

The human estrogen receptor has two independent nonacidic transcriptional activation functions

22 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M211129200

Ligand-dependent, transcriptionally productive association of the amino- and carboxyl-terminal regions of a steroid hormone nuclear receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M211129200

Effects of tamoxifen on bone mineral density in postmenopausal women with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M211129200

Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M211129200

The Effect of Raloxifene on Risk of Breast Cancer in Postmenopausal Women

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M211129200

Inhibition of estrogen receptor-DNA binding by the "pure" antiestrogen ICI 164,384 appears to be mediated by impaired receptor dimerization

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M211129200

Antiestrogen ICI 164,384 reduces cellular estrogen receptor content by increasing its turnover

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M211129200

The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M211129200

Molecular basis of agonism and antagonism in the oestrogen receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M211129200

The tamoxifen-responsive estrogen receptor alpha mutant D351Y shows reduced tamoxifen-dependent interaction with corepressor complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M211129200

Structure-function relationships of the raloxifene-estrogen receptor-alpha complex for regulating transforming growth factor-alpha expression in breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M211129200

Expression of transforming growth factor alpha and its messenger ribonucleic acid in human breast cancer: its regulation by estrogen and its possible functional significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M211129200

Growth regulation of estrogen receptor-negative breast cancer cells transfected with complementary DNAs for estrogen receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M211129200

Specific mutations in the estrogen receptor change the properties of antiestrogens to full agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M211129200

Human estrogen receptor ligand activity inversion mutants: receptors that interpret antiestrogens as estrogens and estrogens as antiestrogens and discriminate among different antiestrogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M211129200

Activation of transcriptionally inactive human estrogen receptors by cyclic adenosine 3',5'-monophosphate and ligands including antiestrogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M211129200

Analysis of mechanisms that determine dominant negative estrogen receptor effectiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M211129200

Irreversible loss of the oestrogen receptor in T47D breast cancer cells following prolonged oestrogen deprivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M211129200

The proteasome, a novel protease regulated by multiple mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M211129200

Proteasome-dependent degradation of the human estrogen receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M211129200

Implication of proteasome in estrogen receptor degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M211129200

Ubiquitin-mediated proteolysis: biological regulation via destruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M211129200

Intracellular targeting of the proteasome

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M211129200

A proteasome howdunit: the case of the missing signal

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M211129200

Structural insights into the mode of action of a pure antiestrogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M211129200

The 26S proteasome is required for estrogen receptor-alpha and coactivator turnover and for efficient estrogen receptor-alpha transactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M211129200

A structural biologist's view of the oestrogen receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M211129200

The oestrogen-like effect of 4-hydroxytamoxifen on induction of transforming growth factor alpha mRNA in MDA-MB-231 breast cancer cells stably expressing the oestrogen receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M211129200

Nuclear receptor coregulators: cellular and molecular biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M211129200

Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M211129200

Molecular determinants for the tissue specificity of SERMs

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M211129200

An estrogen receptor-selective coregulator that potentiates the effectiveness of antiestrogens and represses the activity of estrogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M211129200

Effects of tamoxifen on cardiovascular risk factors in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M211129200

Increasing the number of tandem estrogen response elements increases the estrogenic activity of a tamoxifen analogue

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M211129200

The human estrogen receptor-alpha is a ubiquitinated protein whose stability is affected differentially by agonists, antagonists, and selective estrogen receptor modulators

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M211129200

21 January 2018

Identifiers

DOI

10.1074/JBC.M211129200

1 reference

22 September 2017

1 reference